ALL CONFERENCES

Aesthetic Face & Beyond: How Weight-Loss Drugs Are Reshaping The Beauty Industry

Conference

17/09/2025 | 10h30 - 11h15

The advent of GLP-1 receptor agonists, such as semaglutide (Ozempic) and tirzepatide (Mounjaro), has revolutionized weight management, leading to significant weight loss for many individuals. However, this rapid transformation often brings unintended aesthetic consequences, including facial volume loss, skin laxity, and a gaunt appearance commonly referred to as "Ozempic face" . This session delves into how the surge in GLP-1 medication usage is reshaping the medical aesthetics landscape. We'll explore the increasing demand for non-surgical interventions - such as dermal fillers, biostimulatory agents, and skin-tightening procedures—to address the aesthetic challenges posed by rapid weight loss.  We will see the physiological effects of GLP-1 medications on skin and facial structures, and emerging marketing strategies to effectively communicate and cater to this evolving consumer demographic.

Speakers